Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.34
USPH's Cash to Debt is ranked higher than
50% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 0.34 vs. USPH: 0.34 )
Ranked among companies with meaningful Cash to Debt only.
USPH' s 10-Year Cash to Debt Range
Min: 0.2  Med: 0.78 Max: 298.04
Current: 0.34
0.2
298.04
Equity to Asset 0.58
USPH's Equity to Asset is ranked higher than
68% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. USPH: 0.58 )
Ranked among companies with meaningful Equity to Asset only.
USPH' s 10-Year Equity to Asset Range
Min: 0.31  Med: 0.69 Max: 0.85
Current: 0.58
0.31
0.85
Interest Coverage 42.07
USPH's Interest Coverage is ranked higher than
70% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: 7.17 vs. USPH: 42.07 )
Ranked among companies with meaningful Interest Coverage only.
USPH' s 10-Year Interest Coverage Range
Min: 2.29  Med: 65.14 Max: 9999.99
Current: 42.07
2.29
9999.99
F-Score: 5
Z-Score: 6.36
M-Score: -2.81
WACC vs ROIC
2.26%
18.21%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 14.54
USPH's Operating margin (%) is ranked higher than
74% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 7.02 vs. USPH: 14.54 )
Ranked among companies with meaningful Operating margin (%) only.
USPH' s 10-Year Operating margin (%) Range
Min: 6.43  Med: 14.73 Max: 20.94
Current: 14.54
6.43
20.94
Net-margin (%) 6.65
USPH's Net-margin (%) is ranked higher than
66% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 3.29 vs. USPH: 6.65 )
Ranked among companies with meaningful Net-margin (%) only.
USPH' s 10-Year Net-margin (%) Range
Min: 2.81  Med: 5.95 Max: 8.97
Current: 6.65
2.81
8.97
ROE (%) 15.50
USPH's ROE (%) is ranked higher than
73% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 8.74 vs. USPH: 15.50 )
Ranked among companies with meaningful ROE (%) only.
USPH' s 10-Year ROE (%) Range
Min: 10.36  Med: 16.36 Max: 39.04
Current: 15.5
10.36
39.04
ROA (%) 8.53
USPH's ROA (%) is ranked higher than
79% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 3.45 vs. USPH: 8.53 )
Ranked among companies with meaningful ROA (%) only.
USPH' s 10-Year ROA (%) Range
Min: 6.43  Med: 10.71 Max: 23.68
Current: 8.53
6.43
23.68
ROC (Joel Greenblatt) (%) 133.14
USPH's ROC (Joel Greenblatt) (%) is ranked higher than
93% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 15.85 vs. USPH: 133.14 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
USPH' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 43.09  Med: 65.81 Max: 149.88
Current: 133.14
43.09
149.88
Revenue Growth (3Y)(%) 8.00
USPH's Revenue Growth (3Y)(%) is ranked lower than
52% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. USPH: 8.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
USPH' s 10-Year Revenue Growth (3Y)(%) Range
Min: 7.1  Med: 12.70 Max: 18.3
Current: 8
7.1
18.3
EBITDA Growth (3Y)(%) 3.20
USPH's EBITDA Growth (3Y)(%) is ranked lower than
72% of the 119 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. USPH: 3.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
USPH' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -0.2  Med: 14.50 Max: 28
Current: 3.2
-0.2
28
EPS Growth (3Y)(%) -2.50
USPH's EPS Growth (3Y)(%) is ranked lower than
70% of the 113 Companies
in the Global Medical Care industry.

( Industry Median: 9.90 vs. USPH: -2.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
USPH' s 10-Year EPS Growth (3Y)(%) Range
Min: -2.5  Med: 15.20 Max: 57.8
Current: -2.5
-2.5
57.8
» USPH's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

USPH Guru Trades in Q2 2014

Jim Simons 635,174 sh (+2.80%)
John Keeley Sold Out
Chuck Royce 1,455,929 sh (-4.89%)
» More
Q3 2014

USPH Guru Trades in Q3 2014

Jim Simons 628,874 sh (-0.99%)
Chuck Royce 1,265,210 sh (-13.10%)
» More
Q4 2014

USPH Guru Trades in Q4 2014

Jim Simons 659,074 sh (+4.80%)
Chuck Royce 1,098,171 sh (-13.20%)
Chuck Royce 1,098,171 sh (-13.20%)
» More
Q1 2015

USPH Guru Trades in Q1 2015

Jim Simons 677,827 sh (+2.85%)
Chuck Royce 920,471 sh (-16.18%)
» More
» Details

Insider Trades

Latest Guru Trades with USPH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about US Physical Therapy Inc

USPH: A Small Cap with Big Cap Predictability
Aches, pains and partnerships. That’s the story of U.S. Physical Therapy (NYSE:USPH). Aches and pains, not to mention recovery after surgery, represent a growing market as the population ages, and younger generations hit the tennis courts and running tracks. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 29.60
USPH's P/E(ttm) is ranked lower than
53% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: 26.50 vs. USPH: 29.60 )
Ranked among companies with meaningful P/E(ttm) only.
USPH' s 10-Year P/E(ttm) Range
Min: 8.86  Med: 20.19 Max: 34.07
Current: 29.6
8.86
34.07
Forward P/E 25.51
USPH's Forward P/E is ranked lower than
80% of the 93 Companies
in the Global Medical Care industry.

( Industry Median: 19.31 vs. USPH: 25.51 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 29.50
USPH's PE(NRI) is ranked lower than
54% of the 140 Companies
in the Global Medical Care industry.

( Industry Median: 27.80 vs. USPH: 29.50 )
Ranked among companies with meaningful PE(NRI) only.
USPH' s 10-Year PE(NRI) Range
Min: 8.91  Med: 19.11 Max: 31.71
Current: 29.5
8.91
31.71
P/B 4.37
USPH's P/B is ranked lower than
75% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 2.74 vs. USPH: 4.37 )
Ranked among companies with meaningful P/B only.
USPH' s 10-Year P/B Range
Min: 1.12  Med: 2.67 Max: 4.61
Current: 4.37
1.12
4.61
P/S 2.07
USPH's P/S is ranked lower than
61% of the 218 Companies
in the Global Medical Care industry.

( Industry Median: 1.49 vs. USPH: 2.07 )
Ranked among companies with meaningful P/S only.
USPH' s 10-Year P/S Range
Min: 0.49  Med: 1.22 Max: 2.19
Current: 2.07
0.49
2.19
PFCF 16.68
USPH's PFCF is ranked higher than
65% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 21.20 vs. USPH: 16.68 )
Ranked among companies with meaningful PFCF only.
USPH' s 10-Year PFCF Range
Min: 3.33  Med: 10.37 Max: 17.74
Current: 16.68
3.33
17.74
POCF 14.56
USPH's POCF is ranked higher than
54% of the 151 Companies
in the Global Medical Care industry.

( Industry Median: 15.30 vs. USPH: 14.56 )
Ranked among companies with meaningful POCF only.
USPH' s 10-Year POCF Range
Min: 2.84  Med: 8.67 Max: 15.38
Current: 14.56
2.84
15.38
EV-to-EBIT 15.58
USPH's EV-to-EBIT is ranked higher than
64% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 19.98 vs. USPH: 15.58 )
Ranked among companies with meaningful EV-to-EBIT only.
USPH' s 10-Year EV-to-EBIT Range
Min: 3.9  Med: 8.60 Max: 16.3
Current: 15.58
3.9
16.3
PEG 4.47
USPH's PEG is ranked lower than
67% of the 66 Companies
in the Global Medical Care industry.

( Industry Median: 3.23 vs. USPH: 4.47 )
Ranked among companies with meaningful PEG only.
USPH' s 10-Year PEG Range
Min: 0.64  Med: 1.64 Max: 6.12
Current: 4.47
0.64
6.12
Shiller P/E 35.74
USPH's Shiller P/E is ranked lower than
63% of the 81 Companies
in the Global Medical Care industry.

( Industry Median: 31.33 vs. USPH: 35.74 )
Ranked among companies with meaningful Shiller P/E only.
USPH' s 10-Year Shiller P/E Range
Min: 10.64  Med: 22.06 Max: 37.72
Current: 35.74
10.64
37.72
Current Ratio 2.61
USPH's Current Ratio is ranked higher than
84% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. USPH: 2.61 )
Ranked among companies with meaningful Current Ratio only.
USPH' s 10-Year Current Ratio Range
Min: 1.63  Med: 4.59 Max: 16.64
Current: 2.61
1.63
16.64
Quick Ratio 2.61
USPH's Quick Ratio is ranked higher than
87% of the 203 Companies
in the Global Medical Care industry.

( Industry Median: 1.19 vs. USPH: 2.61 )
Ranked among companies with meaningful Quick Ratio only.
USPH' s 10-Year Quick Ratio Range
Min: 1.63  Med: 4.59 Max: 16.64
Current: 2.61
1.63
16.64
Days Sales Outstanding 42.10
USPH's Days Sales Outstanding is ranked higher than
60% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 46.60 vs. USPH: 42.10 )
Ranked among companies with meaningful Days Sales Outstanding only.
USPH' s 10-Year Days Sales Outstanding Range
Min: 40.46  Med: 57.66 Max: 87.95
Current: 42.1
40.46
87.95

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.02
USPH's Dividend Yield is ranked lower than
71% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. USPH: 1.02 )
Ranked among companies with meaningful Dividend Yield only.
USPH' s 10-Year Dividend Yield Range
Min: 0.31  Med: 1.28 Max: 1.74
Current: 1.02
0.31
1.74
Dividend Payout 0.30
USPH's Dividend Payout is ranked higher than
82% of the 131 Companies
in the Global Medical Care industry.

( Industry Median: 0.43 vs. USPH: 0.30 )
Ranked among companies with meaningful Dividend Payout only.
USPH' s 10-Year Dividend Payout Range
Min: 0.12  Med: 0.24 Max: 5
Current: 0.3
0.12
5
Dividend growth (3y) 14.50
USPH's Dividend growth (3y) is ranked higher than
62% of the 63 Companies
in the Global Medical Care industry.

( Industry Median: 11.90 vs. USPH: 14.50 )
Ranked among companies with meaningful Dividend growth (3y) only.
USPH' s 10-Year Dividend growth (3y) Range
Min: 0  Med: 0.00 Max: 14.5
Current: 14.5
0
14.5
Yield on cost (5-Year) 1.02
USPH's Yield on cost (5-Year) is ranked lower than
79% of the 229 Companies
in the Global Medical Care industry.

( Industry Median: 1.91 vs. USPH: 1.02 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
USPH' s 10-Year Yield on cost (5-Year) Range
Min: 0.31  Med: 1.28 Max: 1.74
Current: 1.02
0.31
1.74
Share Buyback Rate -0.70
USPH's Share Buyback Rate is ranked higher than
70% of the 125 Companies
in the Global Medical Care industry.

( Industry Median: -2.20 vs. USPH: -0.70 )
Ranked among companies with meaningful Share Buyback Rate only.
USPH' s 10-Year Share Buyback Rate Range
Min: 2  Med: -0.40 Max: -6.3
Current: -0.7

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.34
USPH's Price/Projected FCF is ranked higher than
61% of the 96 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. USPH: 1.34 )
Ranked among companies with meaningful Price/Projected FCF only.
USPH' s 10-Year Price/Projected FCF Range
Min: 0.38  Med: 0.86 Max: 3.08
Current: 1.34
0.38
3.08
Price/DCF (Earnings Based) 1.73
USPH's Price/DCF (Earnings Based) is ranked lower than
61% of the 23 Companies
in the Global Medical Care industry.

( Industry Median: 1.43 vs. USPH: 1.73 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.70
USPH's Price/Median PS Value is ranked lower than
79% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. USPH: 1.70 )
Ranked among companies with meaningful Price/Median PS Value only.
USPH' s 10-Year Price/Median PS Value Range
Min: 0.49  Med: 1.00 Max: 2.42
Current: 1.7
0.49
2.42
Price/Peter Lynch Fair Value 5.79
USPH's Price/Peter Lynch Fair Value is ranked lower than
94% of the 50 Companies
in the Global Medical Care industry.

( Industry Median: 2.36 vs. USPH: 5.79 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
USPH' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.47  Med: 1.48 Max: 5.2
Current: 5.79
0.47
5.2
Earnings Yield (Greenblatt) (%) 6.40
USPH's Earnings Yield (Greenblatt) (%) is ranked higher than
72% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 4.10 vs. USPH: 6.40 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
USPH' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 6.1  Med: 11.60 Max: 25.6
Current: 6.4
6.1
25.6
Forward Rate of Return (Yacktman) (%) 10.36
USPH's Forward Rate of Return (Yacktman) (%) is ranked lower than
51% of the 101 Companies
in the Global Medical Care industry.

( Industry Median: 10.96 vs. USPH: 10.36 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
USPH' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 10.1  Med: 19.70 Max: 28.2
Current: 10.36
10.1
28.2

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:UPH.Germany,
US Physical Therapy Inc is incorporated in the state of Nevada in April 1992. The Company, together with its subsidiaries operates outpatient physical and occupational therapy clinics that provide pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. The Company operates 489 clinics in 42 states. Its clinics are concentrated in the states including: Tennessee, Texas, Michigan, Maryland, Washington, New Jersey, Wisconsin, Georgia, Arizona, Virginia, Indiana, Florida and Maine. It also managed 16 physical therapy practices for third parties, primarily physicians. U.S. Physical Therapy operates outpatient physical and occupational therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, preventative care, and rehabilitation of injured workers among others. The Company provides services at its clinics on an outpatient basis. The Company generally charge for treatment on a per procedure basis. Medicare patients are charged based on prescribed time increments and Medicare billing standards. In addition, its clinics will developes individual maintenance and self-management exercise programs to be continued after treatment. It markets its therapy to physicians, including orthopedic surgeons, neurosurgeons, physiatrists, internal medicine physicians, podiatrists, occupational medicine physicians and general practitioners. The Company's operations are subject to federal and state laws.
» More Articles for USPH

Headlines

Articles On GuruFocus.com
USPH: A Small Cap with Big Cap Predictability Oct 08 2014 
Four 'Boring' Stocks to Consider Sep 30 2014 
comment on USPH Jan 24 2013 
12 Healthcare Dividend Stocks with Gaining Earnings Momentum Apr 02 2012 
U.S. Physical Therapy Inc. (USPH) CEO Christopher J Reading sells 25,000 Shares Mar 11 2011 
U.S. Physical Therapy Inc. (USPH) COO Glenn Mcdowell sells 10,614 Shares Mar 11 2011 
U.S. Physical Therapy Inc. Reports Operating Results (10-K) Mar 10 2011 
U.S. Physical Therapy Inc. (USPH) CFO Lawrance W Mcafee sells 5,000 Shares Mar 09 2011 
U.S. Physical Therapy Inc. (USPH) CFO Lawrance W Mcafee sells 15,000 Shares Mar 04 2011 
U.S. Physical Therapy Inc. (USPH) CFO Lawrance W Mcafee sells 5,000 Shares Dec 27 2010 

More From Other Websites
Fenix Parts Announces Anticipated Management Additions, Board Member Changes Jul 15 2015
USPh Schedules Second Quarter 2015 Earnings Release and Conference Call for Thursday, August 6, 2015 Jul 08 2015
U.S. Physical Therapy, Inc. Schedules Second Quarter 2015 Earnings Release and Conference Call for... Jul 08 2015
USPh Completes Another Acquisition - Company Surpasses 500 Clinic Mark Jul 01 2015
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 01 2015
U.S. Physical Therapy Completes Another Acquisition Jul 01 2015
Edited Transcript of USPH earnings conference call or presentation 7-May-15 2:30pm GMT Jun 18 2015
Fenix Parts Announces Anticipated Management Additions, Board Member Changes Jun 17 2015
USPh to Present at the 2015 East Coast IDEAS Investor Conference Jun 01 2015
USPh to Present at the Jefferies 2015 Global Healthcare Conference Jun 01 2015
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... May 29 2015
U.S. Physical Therapy to Present at the Jefferies 2015 Global Healthcare Conference May 29 2015
U.S. Physical Therapy to Present at the 2015 East Coast IDEAS Investor Conference May 29 2015
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 19 2015
U S PHYSICAL THERAPY INC /NV Financials May 15 2015
USPh to Present at the UBS Global Healthcare Conference May 12 2015
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... May 12 2015
U.S. Physical Therapy to Present at the UBS Global Healthcare Conference May 12 2015
U S PHYSICAL THERAPY INC /NV Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... May 07 2015
U.S. Physical Therapy to Present at the Bank of America Merrill Lynch 2015 Health Care Conference May 07 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK